Ligand Pharmaceuticals Inc (LGNDZ) Insider Ownership

Historic Insider Ownership Trends

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
John L Higgins Chief Executive Officer 417,695 0 30 Dec, 2022
Todd C Davis Chief Executive Officer 199,381 0 27 Mar, 2026
Matthew W Foehr President And Coo 162,187 0 03 Nov, 2022
Jason Aryeh - 71,323 0 08 Dec, 2025
Matthew E Korenberg President Coo 50,777 0 24 Sep, 2024
John W Kozarich - 42,253 0 02 Apr, 2026
Andrew Reardon Clo Secretary 41,382 0 02 Apr, 2026
Andrew Reardon Clo Secretary 41,382 0 02 Apr, 2026
Stephen L Sabba - 32,793 0 25 Mar, 2026
Stephen L Sabba - 32,793 0 25 Mar, 2026
John L Lamattina - 30,724 0 31 Mar, 2026
Sunil Patel - 28,820 0 03 Nov, 2022
Sunil Patel - 28,820 0 03 Nov, 2022
Charles S Berkman Svp, Gen. Counsel Secretary 23,825 0 03 Nov, 2022
Octavio Espinoza Chief Financial Officer 21,010 0 13 Mar, 2026
Nancy Ryan Gray - 8,094 0 12 Nov, 2025
Jason Haas - 6,606 0 10 Jun, 2025
Martine Zimmermann - 4,443 0 24 Sep, 2025
Martine Zimmermann - 4,443 0 24 Sep, 2025
Sarah Boyce - 2,892 0 03 Nov, 2022
Jennifer R. Cochran - 1,161 0 03 Nov, 2022

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
01 Apr, 2026 John W Kozarich Common Stock D 146 $199.97 42,574 D S
01 Apr, 2026 Andrew Reardon Common Stock A 5,000 $52.27 46,382 D M
01 Apr, 2026 John W Kozarich Common Stock D 40 $201.24 42,534 D S
01 Apr, 2026 Andrew Reardon Common Stock D 460 $198.85 45,922 D S
01 Apr, 2026 Andrew Reardon Common Stock D 1,302 $199.72 44,620 D S
01 Apr, 2026 John W Kozarich Common Stock D 79 $202.42 42,455 D S
01 Apr, 2026 John W Kozarich Common Stock D 43 $202.91 42,412 D S
01 Apr, 2026 Andrew Reardon Common Stock D 1,238 $200.94 43,382 D S
01 Apr, 2026 Andrew Reardon Common Stock D 700 $201.90 42,682 D S
01 Apr, 2026 John W Kozarich Common Stock D 159 $204.26 42,253 D S
01 Apr, 2026 Andrew Reardon Common Stock D 963 $203.22 41,719 D S
01 Apr, 2026 Andrew Reardon Common Stock D 337 $204.50 41,382 D S
01 Apr, 2026 Andrew Reardon Employee Stock Option (right to buy) D 5,000 $0.00 49,444 D M
06 Mar, 2026 John L Lamattina Common Stock A 2,161 $114.15 32,885 D M
06 Mar, 2026 John L Lamattina Common Stock D 2,161 $200.76 30,724 D S
06 Mar, 2026 John L Lamattina Non-Qualified Stock Option (right to buy) D 2,161 $0.00 0 D M
02 Mar, 2026 Octavio Espinoza Common Stock A 4,933 $0.00 37,945 D A
02 Mar, 2026 Andrew Reardon Common Stock A 4,513 $0.00 41,382 D A
02 Mar, 2026 Todd C Davis Common Stock A 10,495 $0.00 199,381 D A
02 Mar, 2026 Octavio Espinoza Employee Stock Option (right to buy) A 23,527 $0.00 23,527 D A